SMOC1 and breast carcinoma: When MT was expressed in human breast cancer cells we found that the interferon response depended on the presence of RNaseL and interferon regulatory factor 7 (IRF7), the key effector molecules at the proximal and distal ends of the OAS-RNaseL signaling pathway [16].